Mild traumatic brain injury (mTBI) and concussion are important health care issues that present an opportunity for improved care. While many people recover quickly and uneventfully, a proportion of children and adults have ongoing symptoms that may significantly impair function and quality of life. Mild traumatic brain injury and concussion account for 80-90% of all traumatic brain injuries, estimated to occur in 749 per 100,000 person years globally (i.e. approximately 180,000 cases in Australia, and 40,000 cases in New Zealand, every year). They occur most commonly in children, affecting 20% of children under 16 years of age, and adults who are older than 75 years. The incidence is three times higher in Indigenous Australians, and 20% more common in Aotearoa New Zealand Māori and Pasifika populations compared to the non-Indigenous population. The most common causes are falls, mechanical forces, motor vehicle accidents, assault/family violence, and blast-related injury (military personnel). Additionally, individuals sustaining a mTBI/concussion are at increased risk of repeated mTBI/concussion, which often results in more severe and protracted symptoms.
The diagnostic criteria for mild traumatic brain injury were revised in 2023. In brief, firstly, there should be a biomechanically plausible mechanism of injury. In addition, there should be one or more of the following: i) an acute physiological disruption of brain function as manifested by loss of consciousness, alteration in mental status, complete or partial amnesia following the event, or other neurological sign/s; ii) two or more acute symptoms (e.g. subjective altered mental status, physical, cognitive or emotional) and clinical (e.g. cognitive, balance, oculomotor, vestibular-oculomotor signs on examination) or laboratory findings (e.g. blood biomarker indicative of intracranial injury); and iii) neuroimaging evidence of TBI. Lastly, symptoms and signs must not be fully accounted for by an alternative diagnosis or a more severe form of TBI. The term “concussion” can be used interchangeably with mTBI when there is no structural injury on conventional CT or MRI brain. In these guidelines, we use the term mTBI/concussion to avoid confusion.

People with mTBI/concussion are often significantly debilitated after their injury. Symptoms that follow a mTBI are collectively known as Post-Concussion Symptoms (PCS) and Persisting Post-Concussion Symptoms (PPCS) when lasting for longer than one month. Symptoms categorized in four symptom domains: physical (e.g. headaches, dizziness, visual disturbance), cognitive (e.g. problems with attention/concentration, memory difficulties), behavioural (e.g. mood disturbance, anxiety), and sleep/fatigue problems. Children and youth are often thought to have slower recovery rates, 30–40% have post-concussion symptoms for longer that 1 month after injury. There is increasing evidence, however, that as many as 20-50% of adults also have delayed recovery (Nelson; Theadom13). Good acute management including patient education, avoidance of repeat injury, and early follow-up can reduce the risk of PPCS and its significant emotional and financial burden. However, between 40-80% of people leave the emergency department without education or discharge instructions and without a clear follow-up plan.
The management of mTBI/concussion is highly variable across health professionals and there is a lack of knowledge about the best practice and care of people with mTBI/concussion and persistent symptoms. Clinical practice guidelines can help to improve outcomes, optimize resource utilization, and increase cost-effectiveness. There are several evidence-based clinical practice guidelines to help guide the management of mTBI/concussion, however, these have focused on specific populations i.e. children, and sport-related concussion, or are for use in specific settings e.g. the emergency department. However, there are few guidelines that guide the management from injury to recovery, and none that have been adapted for use across the Australian and Aotearoa New Zealand (ANZ) healthcare system.
More information about the guideline

DEVELOPING THE GUIDELINE
The guideline development process commenced with a scoping review to assess the potential for using existing national and international mTBI/concussion clinical practice guidelines as source guidelines. To assess the suitability for use of the potential source guidelines, the scope, methods, transparency in reporting and applicability of the guidelines to the ANZ health care settings were explored.
The scoping review found there was no existing single clinical practice guideline whose coverage completely aligned with that proposed for the ANZ guideline. In addition, most guidelines were developed internationally with applicability concerns for the ANZ context. Therefore, using a single source guideline for the development of the guideline was not appropriate. The scoping review was also used to inform the scope of the guideline in terms of the topics to be addressed.
Due to the breadth of topics to be addressed by the Guideline, the traditional guideline approach of developing research questions and associated eligibility criteria (usually in Population, Intervention, Comparator, Outcome [PICO] format), and de novo evidence reviews to answer the research questions was not feasible. Instead, the guideline was developed using the following main methodologies:
- meta-guideline approach, closely aligned to the ADAPTE approach: a pragmatic process to expedite guideline development through analysis, synthesis and expansion of multiple existing high-quality national and international guidelines
- de novo evidence reviews for topics within the scope of the ANZ Concussion Guideline, but outside the scope of existing high-quality clinical practice guidelines.
The meta-guideline approach identified the following source guidelines:
- Living concussion guidelines: Guideline for concussion and prolonged symptoms for adults 18 years or older 2023
- Paediatric Research in Emergency Departments International Collaborative (PREDICT) 2021 Australian and New Zealand guideline for mild to moderate head injuries in children – Full guideline
- Living guideline for pediatric concussion care 2023
- Centers for Disease Control and Prevention guideline on the diagnosis and management of mild traumatic brain injury among children
- Consensus statement on concussion in sport: the 6th International Conference on Concussion in Sport-Amsterdam, October 2022.
A multidisciplinary group of medical and allied health professionals, who work with mTBI/concussion patients, came together to form the Guideline Development Group (GDG, Appendix A). The GDG included medical specialists (general practice, neurology, neurosurgery, sports medicine, rehabilitation medicine, emergency medicine, geriatrics, rural medicine), allied health (physiotherapy, sport and exercise science, vestibular physiotherapy, neuropsychology), guideline development experts, and academic researchers, across pediatric, adult, elderly populations. The GDG also involved consumer representation and advocates for Aboriginal and Torres Strait Islanders, Māori and Pacifica populations, and people living with disability. Additionally, a Consumer Working Group informed the GDG across scope, lived experience, and areas of need. This group was composed of Australians and New Zealanders who have experienced or cared for a family member with mTBI/concussion, and included Aboriginal and Māori. The GDG was also informed by a subgroup of physiotherapists and occupational therapists who were consulted in areas specific to their expertise. Relevant advice was also sought from subspecialists such as ethicists, haematologists, and geriatricians.

AIM, SCOPE, AUDIENCE
The guideline addresses the care of individuals of all age groups who incur a mTBI/concussion (due to any cause), from injury to recovery and community re-integration.
It is anticipated that availability of a guideline relevant to all people with mTBI/concussion will help to improve outcomes, limit the impact of persisting symptoms, reduce inequalities in mTBI/concussion treatment, and give health professionals confidence to deliver consistent best-practice care. It will provide a framework of contextual recommendations that can be easily and cost-effectively implemented by health professionals as they assess and manage people with mTBI/concussion in their journey from injury to recovery.
In providing these guidelines, the GDG acknowledges:
- in general ANZ societies have become more inclusive and there are greater levels of participation of people with disabilities in the workforce and in community-based sport and recreation settings; with the Paralympic Games now the third largest multi-sport event in the world
- greater involvement of people with a wide range of disabilities, particularly in active sport and recreation settings, increases the likelihood of mTBI/concussion and related contact in the health system
- in general the strength of the recommendations we make are reduced when applied to community dwelling people with certain types of disabilities because the effects of that disability may interact with the effects of mTBI/concussion in ways that are unpredictable and/or make accurate / complete assessment impossible/difficult/invalid. For example:
- people living with moderate or severe traumatic brain injury
- neurodiverse people
- people with intellectual disabilities
- people with poor oro-motor function or other communication difficulties
- people with sensory impairments (vision, hearing).
In other instances (e.g. limb deficiency, short stature) the strength of the recommendations will be unaffected.
It is expected that the primary users of this guideline will be health professionals who are likely to play a role in the assessment and management of people with mTBI/concussion and post-concussive symptoms. As such, these will be health professionals across a wide variety of settings from general practice, emergency departments, medical/surgical specialists, and radiologists to a variety of rehabilitation and sports medicine clinicians in community offices or hospital.

TERMINOLOGY
A “mild traumatic brain injury” is an injury to the brain that occurs following a biomechanical insult to the head or body leading to neurological dysfunction. Neurological dysfunction can be manifested in a variety of signs (such as loss of consciousness, alteration of mental status immediately following the injury, amnesia, and/or other neurological signs) and symptoms (such as confusion, disorientation, headache, balance problems, dizziness, difficulty concentrating and/or emotional symptoms) with or without trauma-related changes on brain imaging. The symptoms and signs of mTBI/concussion should not be better accounted for by another condition/diagnosis or effects of drugs/alcohol/medications and should not meet criteria for more severe forms of TBI. Moderate and severe forms of TBI can be diagnosed when the conscious level is more severely impaired (loss of consciousness for more than 30 minutes, Glasgow Coma Score of less than 13) or the length of post-traumatic amnesia is longer than 24 hours.
The criteria for mTBI were revised by Delphi consensus in 2023 to improve clarity and aid clinical care. In brief, firstly, there should be a biomechanically plausible mechanism of injury. In addition, there should be one or more of the following: i) an acute physiological disruption of brain function as manifested by loss of consciousness, alteration in mental status, complete or partial amnesia following the event, or other neurological sign/s; ii) two or more acute symptoms (e.g. subjective altered mental status, physical, cognitive or emotional) and clinical (e.g. cognitive, balance, oculomotor, vestibular-oculomotor signs on examination) or laboratory findings (e.g. blood biomarker indicative of intracranial injury); and iii) neuroimaging evidence of TBI. Lastly, symptoms and signs must not be fully accounted for by an alternative diagnosis or a more severe form of TBI. The term “concussion” can be used interchangeably with mTBI when there is no structural injury on conventional CT or MRI brain. In these guidelines, we use the term mTBI/concussion to avoid confusion.
Any impact to the head causing injury is considered a “head injury” but does not necessarily mean there has been a brain injury. When communicating that an injury to the brain has occurred, we suggest refraining from using terms such as “head knocks”, “head dings”, “trivial head injury”, or “blow to the head” and that the terms “mild traumatic brain injury” or “concussion” are used instead.
“Physical activity” is any bodily movement produced by skeletal muscles that requires energy expenditure. Exercise is a form of physical activity that is planned, structured, and repetitive and aims to improve physical fitness. Sport refers to a human activity that involves physical exertion and skill as its primary focus, often involving competition or social participation.
In this document, a child is a person between 0 and 18 years. Elderly or old age includes individuals who are 65 years or older, except in Aboriginal and Torres Strait Islander people where old age is considered to be 50 years or older due to the decreased life expectancy in this population. While life expectancy among Māori is also lower than in the general Aotearoa New Zealand population,31 no age range has been specified as “elderly” in this group.
There are select communities and large geographical regions in Australia and Aotearoa New Zealand where access to health care is more limited. The term “appropriately qualified health professional” is used to indicate a licensed health care professional (not necessarily a doctor) whose scope of practice, education, experience, training and accreditation are appropriate for the situation or condition of the patient who is the subject of the consultation or referral. These individuals have a wide range of professional backgrounds and include medical doctors, psychologists, allied health professionals, and indigenous health workers.
There were two topics in particular that produced extensive debate within the GDG. These were return to sport and chronic traumatic encephalopathy. Over the last year, there has been a shift internationally towards a minimum time away from sport. The recommendations from national bodies such as New Zealand Accident Compensation Corporation (ACC), UK government (non-elite sports), and sporting organisations such as World Rugby were reviewed. The GDG also reviewed the protocols across the sporting codes in Australia and Aotearoa New Zealand, most of which did not have a common return to play’ strategy. The evidence guiding return to play decisions was reviewed noting that delaying return to play decreases the risk of repeat injury and improves recovery time but also the lack of evidence supporting optimal timing of return to play. The research demonstrating ongoing changes in brain microstructure even when the person has clinically recovered was also discussed including whether these changes were indication of ongoing recovery or compensatory changes. The GDG was unable to reach unanimous consensus. All agreed that return to play should be individualized. Most members were concerned about the variability in number days away from sport across the sporting codes, that they are not based on evidence, and the potential conflict between timing of return based on the next game day versus player health. The majority of members advised that the lack of a common protocol creates confusion in the community and endorsed a minimum time away from play. A few members did not agree with a minimum time away from sport, the danger that as a result players may not report concussions setting the field back, and that return should be based on the International Conference on Concussion in Sport 2023 alone.
To resolve this issue, a Delphi poll was conducted. In addition to minimum time away from play, the GDG was asked to consider if recommendations should differ between children and adults, all sports versus contact sport, and community versus elite sport. 87% agreed on a fixed time away from contact sport; 66% felt this should apply to all sports (including community sport, 75%); and 86% recommended 21 days away from play (as opposed to 14 or 28 days) in adults and children alike. All agreed that the graduated return to activity paths should be followed to guide recovery as an overriding principle. It was acknowledged that elite athletes were likely to have increased access to specialised medical care to guide recovery when compared to the general community. All agreed that increased community resources will be necessary to facilitate recovery of individuals with concussion/mTBI. This consensus was reached independently, before the recommendations of the Australian Institute of Sport (AIS) were released.
There is increasing pubic concern about the potential link between concussion/mTBI and neurodegenerative disease later in life. The GDG reviewed the evidence, including recent systemic reviews, about whether repetitive head injuries are associated with increased risk of dementia, and neurological problems. As yet, there is no conclusive data to support this risk and so the GDG was unable to develop a recommendation around this. The GDG agreed that the focus of guidance should be on assessment, differential diagnoses and managing treatable symptoms such as mental health issues and practice points were created.

IMPLEMENTATION AND NEXT STEPS
Throughout the guidelines, “Further guidance” sections provide links to contextualised tools and resources. Note that these have not been validated in specific population groups and may not be applicable in all cases.
In addition to engaging stakeholders, following NHMRC guidelines, and ensuring trustworthiness, it is anticipated that implementability of these guidelines will be increased by understanding local contexts obtained by performing a contextual framework analysis identifying factors that need to be considered in final recommendations and any potential barriers and facilitators for its use, including consideration of the:
- needs of Aboriginal and Torres Strait Islander peoples and of Māori abnd Pasifika peoples, especially given their high incidence rate of TBI, and increased risk factors for poor outcome
- difficulties related to accessing services when living in rural and remote areas
- commonly co-occurring problems (e.g. alcohol and/or drug dependency, domestic violence, homelessness)
- consideration of culturally and linguistically diverse populations
- dissemination of the guidelines in different formats (e.g. web-based platforms, Wiki format, open-access publication in medical journals, downloadable files).
It is anticipated that review of the guideline recommendations will be undertaken in 5 years.
This consultation draft is being provided to key stakeholders, professional associations, consumer groups, general public to seek feedback on the clarity of the recommendations, their implementability and feasibility. We also seek input on the accompanying Toolbox and any gaps identified. Following the consultation process, the GDG will review and discuss the public comments, and provide a summary of final changes made in an appendix to the guidelines. An independent review will then be performed, and final guidelines sent for NHMRC approval.